Atlas Trials

Randomized Study of Haploidentical Hct and Subsequent Donor nk Cell Infusion in High-risk AML and MDS

Clinical trial NCT02477787 · TERMINATED

Trial details

NCT number
NCT02477787
Sponsor
Asan Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous Leukemia
Start date
2015-06-01
Primary completion
2019-06-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.